FDA Inspection 1209413 — Fisher Clinical Services, Inc.

Fisher Clinical Services, Inc. — FEI 2529019

The FDA completed an inspection of Fisher Clinical Services, Inc. on June 8, 2023 in Allentown, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 8, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Allentown, PA (United States)